Real-world data in the era of immune checkpoint inhibitors

被引：0
|
作者：
Narita, Yukiya [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-5
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [31] Real-world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer
    Qian, Xiaoyan
    Tao, Yunxia
    Chen, Haizhu
    Li, Xin
    Wang, Yaqin
    Xu, Xiaoming
    Li, Shuo
    Chen, Haoyu
    Cang, Shundong
    Liu, Yang
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [32] From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults
    Loh, Kah Poh
    Wong, Melisa L.
    Maggiore, Ronald
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (03) : 385 - +
  • [33] Effect of immune checkpoint inhibitors in metastatic gastric cancer: A real-world evidence study
    Puccetti, F.
    Mazza, E.
    Hernandez-Ibarburu, G.
    Rusconi, F.
    Liscia, N.
    Barbieri, L. A.
    Treppiedi, E.
    Cossu, A.
    Rosati, R.
    Elmore, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S880 - S880
  • [34] Hyperprogression on immune checkpoint inhibitors: A single institution, real-world retrospective analysis.
    Paydary, Koosha
    Moturi, Krishna Rekha
    Baral, Binav
    Farooq, Muhammad Zain
    Lad, Thomas E.
    Mangla, Ankit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
    Rihawi, Karim
    Giannarelli, Diana
    Galetta, Domenico
    Delmonte, Angelo
    Giavarra, Marco
    Turci, Daniele
    Garassino, Marina
    Tiseo, Marcello
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : E57 - E59
  • [36] Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
    Li, Na
    Feng, Yong
    Chen, Xiaoling
    Li, Ye
    Zhang, Chengmiao
    Yin, Yin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [37] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
    La, Jennifer
    Cheng, David
    Brophy, Mary T.
    Do, Nhan V.
    Lee, Jerry S. H.
    Tuck, David
    Fillmore, Nathanael R.
    JCO CLINICAL CANCER INFORMATICS, 2020, 4 : 918 - 928
  • [39] A real-world analysis of immune checkpoint inhibitors outcomes in patients with baseline auto-immune diseases
    Omar, N. E.
    Elewa, H.
    Saad, M. O.
    Elkhatim, M. Sir
    Alnajjar, A. R.
    Gulied, A.
    Sahal, A.
    Asmar, A.
    Gebril, F. E.
    Afifi, H. M.
    Benkhadra, M.
    Dawoud, R.
    Elazzazy, S.
    Hamad, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1610 - S1610
  • [40] Real-World Treatment with Checkpoint Inhibitors: The Swedish Experience
    Gagatek, S.
    Backman, M.
    Mattsson, J.
    Lamberg, K.
    Brostrom, E.
    Botling, J.
    Micke, P.
    Isaksson, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S978 - S978
12345